Skip to main content

Table 5 Numbers of pathways displaying significant tumor-associated dysregulation in RS analysis of the N vs CRC data set and in independent validation data sets I and II

From: Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon

Differential regulation in CRCs

N vs CRC

V-set I

V-set II

Overlap‡

    

N vs CRC and V-set I

N vs CRC and V-set II

No. upregulated pathways

33

107

157

24 (73%) - *1.1x10-16

27 (82%) - *3.3x10-16

No. downregulated pathways

25

73

58

14 (56%) - *4.6x10-10

9 (36%) - *1.1x10-8

  1. No. of pathways found dysregulated by RS with p-values < 0.05.
  2. ‡ No. (%) of pathways dysregulated in N vs. CRC data set that were similarly dysregulated in the indicated V-set.
  3. * p-values computed by Fisher’s exact test.